Target intelligence / Profile preview

Cellular RNA adenosines susceptible to TadA-8e-mediated deamination (TadA-8e RNA off-targets)

Target
TadA-8e RNA off-targets
Molecular classification
RNA, Other
01

Overview

Cellular RNA adenosines susceptible to low-level TadA-8e-mediated deamination refers to the collection of adenosine residues within the transcriptome that undergo unintended adenosine-to-inosine (A-to-I) conversion by the TadA-8e enzyme. TadA-8e is a highly active, laboratory-evolved variant of the Escherichia coli tRNA adenosine deaminase (TadA) used in CRISPR-based Adenine Base Editors (ABEs) to convert A•T base pairs to G•C in DNA (Richter et al., 2020, Nature Biotechnology). While TadA-8e significantly improves DNA editing efficiency, its high affinity for nucleic acids results in widespread, guide-independent RNA editing (Lapinaite et al., 2020, Science). These off-target RNA modifications can lead to the production of mutant proteins, altered RNA stability, or disrupted splicing patterns, posing potential safety risks for therapeutic applications (Grünewald et al., 2019, Nature). Because these edits occur across the transcriptome rather than at a single therapeutic locus, they are characterized as a systemic off-target effect rather than a traditional drug target. Researchers have developed refined variants, such as TadA-8e-V106W, to mitigate these transcriptome-wide effects while preserving high-efficiency DNA editing (Kim et al., 2019, Nature Biotechnology). Monitoring these susceptible RNA sites is a critical component of the safety assessment for any ABE-based gene therapy.

Other names
RNA off-target editingTadA-8e-mediated RNA deaminationTranscriptome-wide A-to-I editingABE-mediated RNA off-targets
02

Mechanism of action

Hydrolytic deamination of adenosine to inosine in RNA molecules, catalyzed by the TadA-8e enzyme component of a base editor.

03

Biological functions

Post-transcriptional modificationOther
04

Disease associations

Other
05

Safety considerations

Transcriptome-wide off-target effectsPotential for deleterious protein variantsDisruption of RNA regulatory elements
06

Interacting drugs

Adenine Base Editor 8e (ABE8e)

1 more in the full profile.

07

Biomarkers

RNA-seqA-to-I editing frequency

Beyond the preview

Go deeper on Cellular RNA adenosines susceptible to TadA-8e-mediated deamination (TadA-8e RNA off-targets).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular RNA adenosines susceptible to TadA-8e-mediated deamination (TadA-8e RNA off-targets).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call